Cargando…
Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A)
BACKGROUND: In Taiwan, DNA-based newborn screening showed a surprisingly high incidence of a cardiac Fabry mutation (IVS4 + 919G > A). The prevalence of this mutation is too high to be believed that it is a real pathogenic mutation. The purpose of this study is to identify the cardiac pathologic...
Autores principales: | Hsu, Ting-Rong, Sung, Shih-Hsien, Chang, Fu-Pang, Yang, Chia-Feng, Liu, Hao-Chuan, Lin, Hsiang-Yu, Huang, Chun-Kai, Gao, He-Jin, Huang, Yu-Hsiu, Liao, Hsuan-Chieh, Lee, Pi-Chang, Yang, An-Hang, Chiang, Chuan-Chi, Lin, Ching-Yuang, Yu, Wen-Chung, Niu, Dau-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100491/ https://www.ncbi.nlm.nih.gov/pubmed/24980630 http://dx.doi.org/10.1186/1750-1172-9-96 |
Ejemplares similares
-
Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)
por: Lin, Hsiang-Yu, et al.
Publicado: (2013) -
Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation
por: Chien, Yueh, et al.
Publicado: (2016) -
Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey
por: Hsu, Ting-Rong, et al.
Publicado: (2017) -
Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease
por: Chang, Wen-Hsin, et al.
Publicado: (2017) -
Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)
por: Liu, Hao-Chuan, et al.
Publicado: (2014)